Interim report Q3 2020

BioArctic published the company’s Interim Report for the period January – September 2020 on Wednesday, October 14, 2020 at 08:00 a.m. CEST.

Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Neurodegenerative disorders

BioArctic is committed to help people with neurodegenerative disorders

Proud partner of: